See how Teva Pharmaceutical Industries Limited's growth strategy and focus on specialty medicines are driving a turnaround.

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

Several interdisciplinary projects are using virtual and augmented reality to push the frontiers of physical and mental ...

A mini-peptide has been created that delays the early damage caused by Parkinson's disease and promises a way to slow down ...

Symptoms of Parkinson’s disease, which afflicts around 1 million Americans, usually begin gradually and worsen over time.

In this Healio video, David G. Standaert, MD, PhD, discusses a plenary session on protein aggregate clearance in aging brains presented at the 2025 International Congress of Parkinson’s Disease and ...

In this Healio video, Andres Deik, MD, MSEd, FAAN, discusses a presentation about the correlation between genes and environment in the development of Parkinson’s disease.

In the development of Parkinson's disease, it may not be a good idea to turn the amp to 11. High-volume noise exposure ...

As the global population ages, the prevalence of Parkinson’s continues to rise, with an estimated 25 million people expected to be living with the neurological disease by 2050. The incurable ...

Millions worldwide grapple with neurodegenerative diseases like Alzheimer's and Parkinson's. While both worsen over time, ...

Rare diseases reveal that our sense of identity rests on fragile biological infrastructure, much of it operating outside ...

Researchers assessed global trends in early-onset Parkinson Disease, focusing on incident cases, prevalence, years lived with disability, and disability-adjusted life years.